{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:02:21Z","timestamp":1793106141901,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010983","name":"Health Research Fund of Central Denmark Region","doi-asserted-by":"publisher","award":["no reference number"],"award-info":[{"award-number":["no reference number"]}],"id":[{"id":"10.13039\/501100010983","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Foundation","award":["15-B-0160"],"award-info":[{"award-number":["15-B-0160"]}]},{"name":"LSB Foundation","award":["no ref.no. was provided"],"award-info":[{"award-number":["no ref.no. was provided"]}]},{"DOI":"10.13039\/501100007438","name":"Familien Hede Nielsens Fond","doi-asserted-by":"publisher","award":["no ref.no. was provided"],"award-info":[{"award-number":["no ref.no. was provided"]}],"id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010358","name":"KV Fonden","doi-asserted-by":"publisher","award":["no ref.no. was provided"],"award-info":[{"award-number":["no ref.no. was provided"]}],"id":[{"id":"10.13039\/501100010358","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aragon Foundation","award":["no ref.no. was provided"],"award-info":[{"award-number":["no ref.no. was provided"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To reach non-participants, reluctant to undergo clinician-based cervical cancer screening and vaginal self-sampling, urine collection for high-risk human papillomavirus detection (hrHPV) may be valuable. Using two hrHPV DNA assays, we evaluated the concordance of hrHPV positivity in urine samples in comparison with vaginal self-samples and cervical cytology samples taken by the general practitioner (GP). We also studied women\u2019s acceptance of urine collection and preferences towards the different sampling procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      One hundred fifty paired self-collected urine and vaginal samples and GP-collected cervical cytology samples were obtained from 30 to 59-year-old women diagnosed with ASC-US within the Danish cervical cancer screening program. After undergoing cervical cytology at the GP, the women collected first-void urine and vaginal samples at home and completed a questionnaire. Each sample was hrHPV DNA tested by the GENOMICA CLART\u00ae and COBAS\u00ae 4800 assays. Concordance in hrHPV detection between sample types was determined using Kappa (\n                      <jats:italic>k<\/jats:italic>\n                      ) statistics. Sensitivity and specificity of hrHPV detection in urine was calculated using cervical sampling as reference.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      With the COBAS assay, urine showed good concordance to the vaginal (\n                      <jats:italic>k<\/jats:italic>\n                      \u00a0=\u20090.66) self-samples and cervical samples (\n                      <jats:italic>k<\/jats:italic>\n                      \u00a0=\u20090.66) for hrHPV detection. The corresponding concordance was moderate (\n                      <jats:italic>k<\/jats:italic>\n                      \u00a0=\u20090.59 and\n                      <jats:italic>k<\/jats:italic>\n                      \u00a0=\u20090.47) using CLART. Compared to cervical sampling, urinary hrHPV detection had a sensitivity of 63.9% and a specificity of 96.5% using COBAS; compared with 51.6 and 92.4% for CLART. Invalid hrHPV test rates were 1.8% for COBAS and 26.9% for CLART. Urine collection was well-accepted and 42.3% of the women ranked it as the most preferred future screening procedure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Urine collection provides a well-accepted screening option. With COBAS, higher concordance between urine and vaginal self-sampling and cervical sampling for hrHPV detection was found compared to CLART. Urinary hrHPV detection with COBAS is feasible, but its accuracy may need to be improved before urine collection at home can be offered to non-participants reluctant to both cervical sampling and vaginal self-sampling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05663-7","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T07:04:34Z","timestamp":1607065474000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Urine collection in cervical cancer screening \u2013 analytical comparison of two HPV DNA assays"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-6694","authenticated-orcid":false,"given":"Mette","family":"Tranberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-7435","authenticated-orcid":false,"given":"J\u00f8rgen Skov","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0287-3687","authenticated-orcid":false,"given":"Bodil Hammer","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4074-6504","authenticated-orcid":false,"given":"Berit","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"5663_CR1","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","volume":"30","author":"M Arbyn","year":"2012","unstructured":"Arbyn M, Ronco G, Anttila A, Meijer CJLM, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30:F88\u201399.","journal-title":"Vaccine"},{"issue":"9916","key":"5663_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstr\u00f6m KM, Tunesi S, Snijders PJF, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"key":"5663_CR3","doi-asserted-by":"publisher","first-page":"k4823","DOI":"10.1136\/bmj.k4823","volume":"363","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. Bmj. 2018;363:k4823.","journal-title":"Bmj"},{"issue":"1","key":"5663_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12885-018-4165-4","volume":"18","author":"M Tranberg","year":"2018","unstructured":"Tranberg M, Bech BH, Blaak\u00e6r J, Jensen JS, Svanholm H, Andersen B. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures-a randomized controlled trial. BMC Cancer. 2018;18(1):273.","journal-title":"BMC Cancer"},{"issue":"1","key":"5663_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/sextrans-2016-052609","volume":"93","author":"EJ Nelson","year":"2017","unstructured":"Nelson EJ, Maynard BR, Loux T, Fatla J, Gordon R, Arnold LD. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sex Transm Infect. 2017;93(1):56\u201361.","journal-title":"Sex Transm Infect"},{"issue":"10","key":"5663_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/14787210.2019.1668776","volume":"17","author":"J Pattyn","year":"2019","unstructured":"Pattyn J, Van Keer S, T\u00e9blick L, Van Damme P, Vorsters A. HPV DNA detection in urine samples of women: 'an efficacious and accurate alternative to cervical samples?'. Expert Rev Anti Infect Ther. 2019;17(10):755\u20137.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5663_CR7","doi-asserted-by":"crossref","unstructured":"Lefeuvre C, Pivert A, Guillou-Guillemette HL, Lunel-Fabiani F, Veillon P, Le Duc-Banaszuk AS, et al. Urinary HPV DNA testing as a tool for cervical cancer screening in women who are reluctant to have a pap smear in France. J Inf Secur. 2020;81(2):248\u201354.","DOI":"10.1016\/j.jinf.2020.05.006"},{"key":"5663_CR8","doi-asserted-by":"publisher","first-page":"g5264","DOI":"10.1136\/bmj.g5264","volume":"349","author":"N Pathak","year":"2014","unstructured":"Pathak N, Dodds J, Zamora J, Khan K. Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. BMJ. 2014;349:g5264.","journal-title":"BMJ"},{"issue":"8","key":"5663_CR9","first-page":"4183","volume":"37","author":"KC Asciutto","year":"2017","unstructured":"Asciutto KC, Henningsson AJ, Borgfeldt H, Darlin L, Borgfeldt C. Vaginal and urine self-sampling compared to cervical sampling for HPV-testing with the Cobas 4800 HPV test. Anticancer Res. 2017;37(8):4183\u20137.","journal-title":"Anticancer Res"},{"issue":"4","key":"5663_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025388","volume":"9","author":"A Sargent","year":"2019","unstructured":"Sargent A, Fletcher S, Bray K, Kitchener HC, Crosbie EJ. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening. BMJ Open. 2019;9(4):e025388.","journal-title":"BMJ Open"},{"issue":"7","key":"5663_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/jclinpath-2014-202851","volume":"68","author":"GA Stanczuk","year":"2015","unstructured":"Stanczuk GA, Currie H, Baxter G, Foster A, Gibson L, Graham C, et al. Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment. J Clin Pathol. 2015;68(7):567\u201370.","journal-title":"J Clin Pathol"},{"key":"5663_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jviromet.2019.04.012","volume":"269","author":"HW Cho","year":"2019","unstructured":"Cho HW, Ouh YT, Hong JH, Min KJ, So KA, Kim TJ, et al. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay. J Virol Methods. 2019;269:77\u201382.","journal-title":"J Virol Methods"},{"issue":"5","key":"5663_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10096-017-3179-1","volume":"37","author":"S Van Keer","year":"2018","unstructured":"Van Keer S, Tjalma WAA, Pattyn J, Biesmans S, Pieters Z, Van Ostade X, et al. Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples. Eur J Clin Microbiol Infect Dis. 2018;37(5):859\u201369.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"5663_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jcv.2014.10.001","volume":"61","author":"S Bernal","year":"2014","unstructured":"Bernal S, Palomares JC, Artura A, Parra M, Cabezas JL, Robles A, et al. Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test. J Clin Virol. 2014;61(4):548\u201352.","journal-title":"J Clin Virol"},{"issue":"7","key":"5663_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1158\/1055-9965.EPI-16-0960","volume":"26","author":"J Cuzick","year":"2017","unstructured":"Cuzick J, Cadman L, Ahmad AS, Ho L, Terry G, Kleeman M, et al. Performance and diagnostic accuracy of a urine-based human papillomavirus assay in a referral population. Cancer Epidemiol Biomarkers Prev. 2017;26(7):1053\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"5663_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/1471-0528.14682","volume":"124","author":"A Leeman","year":"2017","unstructured":"Leeman A, Del Pino M, Molijn A, Rodriguez A, Torn\u00e9 A, de Koning M, et al. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population. BJOG. 2017;124(9):1356\u201363.","journal-title":"BJOG"},{"issue":"5","key":"5663_CR17","first-page":"513","volume":"163","author":"JW Sellors","year":"2000","unstructured":"Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ : Can Medi Assoc J= journal de l'Association medicale canadienne. 2000;163(5):513\u20138.","journal-title":"CMAJ : Can Medi Assoc J= journal de l'Association medicale canadienne"},{"key":"5663_CR18","unstructured":"Danish Health Authority. Screening for livmoderhalskr\u00e6ft-anbefalinger 2012 [In English: cervical cancer screening-recommendations 2012]. Copenhagen [in Danish with English summary] [https:\/\/www.sst.dk\/~\/media\/B1211EAFEDFB47C5822E883205F99B79.ashx]."},{"key":"5663_CR19","doi-asserted-by":"crossref","unstructured":"Tranberg M, Jensen JS, Bech BH, Blaakaer J, Svanholm H, Andersen B. Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test. BMC Infect Dis. 2018;18:348.","DOI":"10.1186\/s12879-018-3254-y"},{"issue":"6","key":"5663_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1365-2303.2006.00386.x","volume":"17","author":"CE Depuydt","year":"2006","unstructured":"Depuydt CE, Benoy IH, Bailleul EJ, Vandepitte J, Vereecken AJ, Bogers JJ. Improved endocervical sampling and HPV viral load detection by Cervex-brush combi. Cytopathology. 2006;17(6):374\u201381.","journal-title":"Cytopathology"},{"issue":"12","key":"5663_CR21","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1128\/JCM.01506-12","volume":"50","author":"R van Baars","year":"2012","unstructured":"van Baars R, Bosgraaf RP, ter Harmsel BW, Melchers WJ, Quint WG, Bekkers RL. Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn brush, providing reliable human papillomavirus detection combined with comfort for women. J Clin Microbiol. 2012;50(12):3937\u201343.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"5663_CR22","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1128\/JCM.03386-12","volume":"51","author":"A Rao","year":"2013","unstructured":"Rao A, Young S, Erlich H, Boyle S, Krevolin M, Sun R, et al. Development and characterization of the cobas human papillomavirus test. J Clin Microbiol. 2013;51(5):1478\u201384.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"5663_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12885-020-06888-0","volume":"20","author":"DM Ejegod","year":"2020","unstructured":"Ejegod DM, Lagheden C, Bhatia R, Pedersen H, Boada EA, Sundstr\u00f6m K, et al. Clinical validation of full genotyping CLART\u00ae HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening. BMC Cancer. 2020;20(1):396.","journal-title":"BMC Cancer"},{"key":"5663_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/CLEP.S9908","volume":"2","author":"R Erichsen","year":"2010","unstructured":"Erichsen R, Lash TL, Hamilton-Dutoit SJ, Bjerregaard B, Vyberg M, Pedersen L. Existing data sources for clinical epidemiology: the Danish National Pathology Registry and data Bank. Clin Epidemiol. 2010;2:51\u20136.","journal-title":"Clin Epidemiol"},{"key":"5663_CR25","doi-asserted-by":"crossref","unstructured":"Altman DG. Practical statistics for medical research: Chapman and Hall\/CRC; 1991..","DOI":"10.1201\/9780429258589"},{"key":"5663_CR26","doi-asserted-by":"publisher","first-page":"104336","DOI":"10.1016\/j.jcv.2020.104336","volume":"128","author":"DM Ejegod","year":"2020","unstructured":"Ejegod DM, Hansen M, Christiansen IK, Pedersen H, Quint W, Xu L, et al. Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework. J Clin Virol. 2020;128:104336.","journal-title":"J Clin Virol"},{"issue":"11","key":"5663_CR27","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1128\/JCM.05552-11","volume":"49","author":"DA Heideman","year":"2011","unstructured":"Heideman DA, Hesselink AT, Berkhof J, van Kemenade F, Melchers WJ, Daalmeijer NF, et al. Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol. 2011;49(11):3983\u20135.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"5663_CR28","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s10096-014-2147-2","volume":"33","author":"A Vorsters","year":"2014","unstructured":"Vorsters A, Van den Bergh J, Micalessi I, Biesmans S, Bogers J, Hens A, et al. Optimization of HPV DNA detection in urine by improving collection, storage, and extraction. Eur J Clin Microbiol Infect Dis. 2014;33(11):2005\u201314.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"5663_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010660","volume":"6","author":"G Stanczuk","year":"2016","unstructured":"Stanczuk G, Baxter G, Currie H, Lawrence J, Cuschieri K, Wilson A, et al. Clinical validation of hrHPV testing on vaginal and urine self-samples in primary cervical screening (cross-sectional results from the papillomavirus Dumfries and Galloway-PaVDaG study). BMJ Open. 2016;6(4):e010660 -012015-010660.","journal-title":"BMJ Open"},{"issue":"10","key":"5663_CR30","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/jmv.22167","volume":"83","author":"SL Bissett","year":"2011","unstructured":"Bissett SL, Howell-Jones R, Swift C, De Silva N, Biscornet L, Parry JV, et al. Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol. 2011;83(10):1744\u201351.","journal-title":"J Med Virol"},{"key":"5663_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jviromet.2018.11.008","volume":"264","author":"J Pattyn","year":"2019","unstructured":"Pattyn J, Van Keer S, Biesmans S, Ieven M, Vanderborght C, Beyers K, et al. Human papillomavirus detection in urine: effect of a first-void urine collection device and timing of collection. J Virol Methods. 2019;264:23\u201330.","journal-title":"J Virol Methods"},{"issue":"5","key":"5663_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/jcp.44.5.360","volume":"44","author":"G Khan","year":"1991","unstructured":"Khan G, Kangro HO, Coates PJ, Heath RB. Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. J Clin Pathol. 1991;44(5):360\u20135.","journal-title":"J Clin Pathol"},{"issue":"4","key":"5663_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/mcpr.1997.0109","volume":"11","author":"MA Chernesky","year":"1997","unstructured":"Chernesky MA, Jang D, Sellors J, Luinstra K, Chong S, Castriciano S, et al. Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing chlamydia trachomatis infected women. Mol Cell Probes. 1997;11(4):243\u20139.","journal-title":"Mol Cell Probes"},{"key":"5663_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jcv.2018.08.006","volume":"107","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Peeters E, Benoy I, Vanden Broeck D, Bogers J, De Sutter P, et al. VALHUDES: a protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples. J Clin Virol. 2018;107:52\u20136.","journal-title":"J Clin Virol"},{"issue":"7","key":"5663_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/01443610903061736","volume":"29","author":"A Sehgal","year":"2009","unstructured":"Sehgal A, Gupta S, Parashari A, Sodhani P, Singh V. Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices. J Obstet Gynaecol. 2009;29(7):583\u20139.","journal-title":"J Obstet Gynaecol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05663-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05663-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05663-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T07:06:41Z","timestamp":1607065601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05663-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5663"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05663-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-44091\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-44091\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"16 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local Ethical Committee of the Central Denmark Region (journal no.: 1\u201316\u201302-209-15) and by the Danish Data Protection Agency (journal no.: 1\u201310\u201372-69-15). Further, all women provided their written informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Axlab, the Danish manufacturer of the Evalyn\u00ae Brush, provided self-sampling devices for the study. In accordance with the contract between the manufacturers and the Department of Public Health Programmes, Randers Regional Hospital, Axlab had no influence on the scientific process and no editorial rights pertaining to this manuscript. The authors retained the right to submit the manuscript. None of the authors were compensated for their work on this study, have any shares in the manufacturers\u2019 companies, or received bonuses from any of the manufacturers. MT, JSJ, BHB, and BA have participated in other studies with HPV test kits sponsored by Roche and self-sampling devices sponsored by Axlab. MT has received honoraria from Roche Diagnostics and AstraZeneca for lectures on HPV self-sampling and HPV triage-methods. The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"926"}}